Literature DB >> 11081175

Role of gamma knife radiosurgery in acromegaly.

I M Jackson1, G Noren.   

Abstract

Stereotactic radiosurgery with the Gamma Knife allows the delivery of focused radiation in a single session from a Cobalt-60 source to a pituitary tumor with little radiation to surrounding normal brain tissue. At this time the major role for Gamma Knife radiosurgery in acromegaly is for the treatment of failed pituitary surgery although it may also by used as primary treatment for patients unwilling or unsuitable, for medical reasons, to undergo transsphenoidal surgery. The major risk from Gamma Knife radiosurgery appears to be radiation damage to the visual pathways, but this can be obviated by limiting the radiation dose to the optic chiasm under 10 Gy. In contrast, the neuronal and vascular structures running in the cavernous sinus are much less radiosensitive allowing an ablative dose to be administered to tumors showing lateral invasion and impinging on cranial nerves III, IV, V and VI. Gamma Knife radiosurgery appears to produce effects in GH secreting tumors faster than with fractionated radiotherapy without the potential long-term risk of developing a second extrapituitary brain tumor as well as the neuropsychiatric effects associated with conventional radiation administration.

Entities:  

Mesh:

Year:  1999        PMID: 11081175     DOI: 10.1023/a:1009926122406

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  31 in total

1.  Tight control of growth hormone: an attainable outcome for acromegaly treatment.

Authors:  S Melmed
Journal:  J Clin Endocrinol Metab       Date:  1998-10       Impact factor: 5.958

Review 2.  Acromegaly.

Authors:  S Melmed
Journal:  N Engl J Med       Date:  1990-04-05       Impact factor: 91.245

Review 3.  Stereotactic radiosurgery of pituitary adenomas.

Authors:  E D Motti; M Losa; S Pieralli; A Zecchinelli; B Longobardi; E Giugni; L Ventrella
Journal:  Metabolism       Date:  1996-08       Impact factor: 8.694

Review 4.  Gamma Knife treatment of pituitary adenomas.

Authors:  J C Ganz
Journal:  Stereotact Funct Neurosurg       Date:  1995       Impact factor: 1.875

5.  Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma.

Authors:  M Brada; D Ford; S Ashley; J M Bliss; S Crowley; M Mason; B Rajan; D Traish
Journal:  BMJ       Date:  1992-05-23

Review 6.  Current treatment guidelines for acromegaly.

Authors:  S Melmed; I Jackson; D Kleinberg; A Klibanski
Journal:  J Clin Endocrinol Metab       Date:  1998-08       Impact factor: 5.958

7.  Gamma knife surgery in pituitary microadenomas.

Authors:  Y G Park; J W Chang; E Y Kim; S S Chung
Journal:  Yonsei Med J       Date:  1996-06       Impact factor: 2.759

8.  Stereotactic radiosurgery: the Lyon experience.

Authors:  F P Rocher; I Sentenac; C Berger; I Marquis; P Romestaing; J P Gerard
Journal:  Acta Neurochir Suppl       Date:  1995

9.  Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly.

Authors:  B Swearingen; F G Barker; L Katznelson; B M Biller; S Grinspoon; A Klibanski; N Moayeri; P M Black; N T Zervas
Journal:  J Clin Endocrinol Metab       Date:  1998-10       Impact factor: 5.958

10.  The effects of Gamma Knife surgery of pituitary adenomas on tumor growth and endocrinopathies.

Authors:  J C Ganz; E O Backlund; F A Thorsen
Journal:  Stereotact Funct Neurosurg       Date:  1993       Impact factor: 1.875

View more
  7 in total

1.  Gamma knife radiosurgery for clinically persistent acromegaly.

Authors:  Xiaomin Liu; Hideyuki Kano; Douglas Kondziolka; Kyung-Jae Park; Aditya Iyer; Ajay Niranjan; John C Flickinger; L Dade Lunsford
Journal:  J Neurooncol       Date:  2012-04-26       Impact factor: 4.130

Review 2.  Medical management of growth hormone-secreting pituitary adenomas.

Authors:  Michael S Racine; Ariel L Barkan
Journal:  Pituitary       Date:  2002       Impact factor: 4.107

Review 3.  Modern treatment of acromegaly.

Authors:  Z Merza
Journal:  Postgrad Med J       Date:  2003-04       Impact factor: 2.401

Review 4.  Current status and future opportunities for controlling acromegaly.

Authors:  Shlomo Melmed; Mary Lee Vance; Ariel L Barkan; Bengt-Ake Bengtsson; David Kleinberg; Anne Klibanski; Peter J Trainer
Journal:  Pituitary       Date:  2002       Impact factor: 4.107

Review 5.  Resistance to somatostatin analogs in acromegaly: an evolving concept?

Authors:  M Gola; S Bonadonna; G Mazziotti; G Amato; A Giustina
Journal:  J Endocrinol Invest       Date:  2006-01       Impact factor: 4.256

Review 6.  Gamma knife radiosurgery in the management of patients with acromegaly: a review.

Authors:  A S Mahmoud-Ahmed; J H Suh; M R Mayberg
Journal:  Pituitary       Date:  2001-09       Impact factor: 4.107

7.  Results of gamma knife radiosurgery in acromegaly.

Authors:  Alberto Franzin; Giorgio Spatola; Marco Losa; Piero Picozzi; Pietro Mortini
Journal:  Int J Endocrinol       Date:  2012-02-19       Impact factor: 3.257

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.